FGFR3 and eIF4E were previously reported to frequently overexpress in lung cancer, myeloma, and ovarian cancers (van Rhijn et al., 2001; De Benedetti and Graff, 2004; Culjkovic-Kraljacic et al., 2012), thus playing an important role in tumor occurrence and development. Here, FGFR3 is linked to lung carcinoma.